Latest Regulatory News

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Iris Cairns Property Pty Ltd has announced a delay in its takeover bid for Reef Casino Trust due to extended regulatory approval timelines, signaling a planned extension of the offer period beyond May 2026.

Microequities Asset Management Group Limited has announced an on-market buy-back of up to 13.27 million shares, representing roughly 10% of its issued capital, signaling a strategic capital management move.

Capricorn Metals Ltd’s CMMO securities have been reinstated to trading on the ASX after meeting compliance requirements, signaling renewed market activity. Investors will be watching closely to gauge the impact on liquidity and price movement.

Metcash Limited has responded to an ASX query regarding the late filing of a director’s interest notice, attributing the delay to an administrative oversight and outlining plans to enhance compliance processes.

Warriedar Resources has completed its acquisition by Capricorn Metals through a court-approved scheme, with shareholders exchanging their shares for Capricorn stock. The takeover triggers Warriedar’s removal from the ASX next week.

Reef Casino Trust has lodged a supplementary statement revealing delays in regulatory approvals that are likely to extend the takeover bid timeline by Iris Cairns Property. The board maintains its recommendation to accept the offer despite the uncertainty.

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Stakk Limited has expanded its partnership with T-Mobile Money, adding advanced fraud and risk modules to its embedded finance platform, potentially accelerating revenue growth within one of the largest US consumer ecosystems.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Reef Casino Trust’s takeover bid by Iris Cairns Property faces a regulatory hurdle as Queensland’s Office of Liquor and Gaming Regulation delays suitability investigations, pushing the offer period beyond March 2026.

Element 25 Limited is making significant strides in expanding its Butcherbird Manganese Mine, securing $60 million in funding and advancing critical engineering and contract milestones to boost manganese concentrate production to 1.1 million tonnes per annum.